The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigenpresentation and immune-proteasome pathways

Journal of General Virology

Volumn 92, Issue 9, 2011, Pages 2093-2104

  Tisoncik, Jennifer R ^a   Billharz, Rosalind ^a   Burmakina, Svetlana ^b   Belisle, Sarah E ^a   Proll, Sean C ^a   Korth, Marcus J ^a   García Sastre, Adolfo ^b   Katze, Michael G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BETA 2 MICROGLOBULIN; BETA INTERFERON; CASPASE 10; CASPASE 5; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; CXCL2 CHEMOKINE; DEAD BOX PROTEIN; GUANYLATE BINDING PROTEIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS KINASE EPSILON; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 2; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 3; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1BETA CONVERTING ENZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MUCIN 1; NONSTRUCTURAL PROTEIN 1; NUCLEAR FACTOR IFN INDUCIBLE; PROTEASOME; PROTEIN; TRANSPORTER 1 ATP BINDING CASSETTE SUBFAMILY B; TRANSPORTER 2 ATP BINDING CASSETTE SUBFAMILY B; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE CONTROL; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE GENE; INFLUENZA VIRUS A H1N1; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS MUTANT; VIRUS TRANSCRIPTION; WILD TYPE;

ANTIGEN PRESENTATION; CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INTERFERON-ALPHA; INTERFERON-BETA; MUTANT PROTEINS; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE FACTORS;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 80051728300     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.032060-0     Document Type: Article

References (46)

1. Baskin, C. R., Bielefeldt-Ohmann, H., García-Sastre, A., Tumpey, T. M., Van Hoeven, N., Carter, V. S., Thomas, M. J., Proll, S., Solórzano, A. & other authors (2007). Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus. J Virol 81, 11817-11827.
2. Billharz, R., Zeng, H., Proll, S. C., Korth, M. J., Lederer, S., Albrecht, R., Goodman, A. G., Rosenzweig, E., Tumpey, T. M. & other authors (2009). The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J Virol 83, 10557-10570.
3. Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C. A. & other authors (2001). Minimum information about a microarray experiment (MIAME) -toward standards for microarray data. Nat Genet 29, 365-371.
4. Chatterjee-Kishore, M., Kishore, R., Hicklin, D. J., Marincola, F. M. & Ferrone, S. (1998). Different requirements for signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated with antigen processing 1 gene expression. J Biol Chem 273, 16177-16183.
5. Chatterjee-Kishore, M., van Den Akker, F. & Stark, G. R. (2000). Adenovirus E1A down-regulates LMP2 transcription by interfering with the binding of stat1 to IRF1. J Biol Chem 275, 20406-20411.
6. Chen, Z., Li, Y. & Krug, R. M. (1999). Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 39-end processing machinery. EMBO J 18, 2273-2283.
7. Chien, C. Y., Tejero, R., Huang, Y., Zimmerman, D. E., Ríos, C. B., Krug, R. M. & Montelione, G. T. (1997). A novel RNA-binding motif in influenza A virus non-structural protein 1. Nat Struct Biol 4, 891-895.
8. Chien, C. Y., Xu, Y., Xiao, R., Aramini, J. M., Sahasrabudhe, P. V., Krug, R. M. & Montelione, G. T. (2004). Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. Biochemistry 43, 1950-1962.
9. Darnell, J. E., Jr, Kerr, I. M. & Stark, G. R. (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
10. de Graaf, N., van Helden, M. J., Textoris-Taube, K., Chiba, T., Topham, D. J., Kloetzel, P. M., Zaiss, D. M. & Sijts, A. J. (2011). PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo. Eur J Immunol 41, 926-935.
11. Fernandez-Sesma, A., Marukian, S., Ebersole, B. J., Kaminski, D., Park, M. S., Yuen, T., Sealfon, S. C., García-Sastre, A. & Moran, T. M. (2006). Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 80, 6295-6304.
12. Frontini, M., Vijayakumar, M., Garvin, A. & Clarke, N. (2009). A ChIPchip approach reveals a novel role for transcription factor IRF1 in the DNA damage response. Nucleic Acids Res 37, 1073-1085.
13. Gack, M. U., Albrecht, R. A., Urano, T., Inn, K. S., Huang, I. C., Carnero, E., Farzan, M., Inoue, S., Jung, J. U. & García-Sastre, A. (2009). Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5, 439-449.
14. García-Sastre, A. (2001). Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279, 375-384.
15. Garfinkel, M. S. & Katze, M. G. (1992). Translational control by influenza virus. Selective and cap-dependent translation of viral mRNAs in infected cells. J Biol Chem 267, 9383-9390.
16. Geiss, G. K., Salvatore, M., Tumpey, T. M., Carter, V. S., Wang, X., Basler, C. F., Taubenberger, J. K., Bumgarner, R. E., Palese, P. & other authors (2002). Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A 99, 10736-10741.
17. Goodman, A. G., Smith, J. A., Balachandran, S., Perwitasari, O., Proll, S. C., Thomas, M. J., Korth, M. J., Barber, G. N., Schiff, L. A. & Katze, M. G. (2007). The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism. J Virol 81, 2221-2230.
18. Guo, Z., Chen, L. M., Zeng, H., Gomez, J. A., Plowden, J., Fujita, T., Katz, J. M., Donis, R. O. & Sambhara, S. (2007). NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 36, 263-269.
19. Hale, B. G., Steel, J., Medina, R.A., Manicassamy, B., Ye, J., Hickman, D., Hai, R., Schmolke, M., Lowen, A. C. & other authors (2010). Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol 84, 6909-6922.
20. Haye, K., Burmakina, S., Moran, T., García-Sastre, A. & Fernandez-Sesma, A. (2009). The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. J Virol 83, 6849-6862.
21. Jackson, D., Hossain, M. J., Hickman, D., Perez, D. R. & Lamb, R. A. (2008). A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 105, 4381-4386.
22. Katze, M. G. & Krug, R. M. (1990). Translational control in influenza virus-infected cells. Enzyme 44, 265-277.
23. Katze, M. G., Detjen, B. M., Safer, B. & Krug, R. M. (1986). Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs. Mol Cell Biol 6, 1741-1750.
24. Katze, M. G., Tomita, J., Black, T., Krug, R. M., Safer, B. & Hovanessian, A. (1988). Influenza virus regulates protein synthesis during infection by repressing autophosphorylation and activity of the cellular 68,000-Mr protein kinase. J Virol 62, 3710-3717.
25. Kochs, G., García-Sastre, A. & Martínez-Sobrido, L. (2007). Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81, 7011-7021.
26. Liu, J., Lynch, P. A., Chien, C. Y., Montelione, G. T., Krug, R. M. & Berman, H. M. (1997). Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat Struct Biol 4, 896-899.
27. Liu, H., Golebiewski, L., Dow, E. C., Krug, R. M., Javier, R. T. & Rice, A. P. (2010). The ESEV PDZ-binding motif of the avian influenza A virus NS1 protein protects infected cells from apoptosis by directly targeting Scribble. J Virol 84, 11164-11174.
28. Livak, K. J. & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCt method. Methods 25, 402-408.
29. Lu, Y., Wambach, M., Katze, M. G. & Krug, R. M. (1995). Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the eIF-2 translation initiation factor. Virology 214, 222-228.
30. Mibayashi, M., Martínez-Sobrido, L., Loo, Y. M., Cárdenas, W. B., Gale, M., Jr & García-Sastre, A. (2007). Inhibition of retinoic acidinducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81, 514-524.
31. Nemeroff, M. E., Barabino, S. M., Li, Y., Keller, W. & Krug, R. M. (1998). Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 39 end formation of cellular premRNAs. Mol Cell 1, 991-1000.
32. Noah, D. L., Twu, K. Y. & Krug, R. M. (2003). Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 39 end processing of cellular pre-mRNAS. Virology 307, 386-395.
33. Nussbaum, A. K., Rodriguez-Carreno, M. P., Benning, N., Botten, J. & Whitton, J. L. (2005). Immunoproteasome-deficient mice mount largely normal CD8+ T cell responses to lymphocytic choriomeningitis virus infection and DNA vaccination. J Immunol 175, 1153-1160.
34. Obenauer, J. C., Denson, J., Mehta, P. K., Su, X., Mukatira, S., Finkelstein, D. B., Xu, X., Wang, J., Ma, J. & other authors (2006). Large-scale sequence analysis of avian influenza isolates. Science 311, 1576-1580.
35. Opitz, B., Rejaibi, A., Dauber, B., Eckhard, J., Vinzing, M., Schmeck, B., Hippenstiel, S., Suttorp, N. & Wolff, T. (2007). IFNb induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9, 930-938.
36. Park, M. S., Shaw, M. L., Muñoz-Jordan, J., Cros, J. F., Nakaya, T., Bouvier, N., Palese, P., García-Sastre, A. & Basler, C. F. (2003). Newcastle disease virus (NDV)-based assay demonstrates interferonantagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol 77, 1501-1511.
37. Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F. & Reis e Sousa, C. (2006). RIG-I-mediated antiviral responses to single-stranded RNA bearing 59-phosphates. Science 314, 997-1001.
38. Quinlivan, M., Zamarin, D., García-Sastre, A., Cullinane, A., Chambers, T. & Palese, P. (2005). Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol 79, 8431-8439.
39. Seifert, U., Bialy, L. P., Ebstein, F., Bech-Otschir, D., Voigt, A., Schröter, F., Prozorovski, T., Lange, N., Steffen, J. & other authors (2010). Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell 142, 613-624.
40. Solórzano, A., Webby, R. J., Lager, K. M., Janke, B. H., García-Sastre, A. & Richt, J. A. (2005). Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs. J Virol 79, 7535-7543.
41. Steel, J., Burmakina, S. V., Thomas, C., Spackman, E., García-Sastre, A., Swayne, D. E. & Palese, P. (2008). A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus. Vaccine 26, 522-531.
42. Thanos, D. & Maniatis, T. (1995). Virus induction of human IFN b gene expression requires the assembly of an enhanceosome. Cell 83, 1091-1100.
43. Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J. & Fukuda, K. (2003). Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289, 179-186.
44. Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Bridges, C. B., Cox, N. J. & Fukuda, K. (2004). Influenza-associated hospitalizations in the United States. JAMA 292, 1333-1340.
45. Wang, X., Li, M., Zheng, H., Muster, T., Palese, P., Beg, A. A. & García-Sastre, A. (2000). Influenza A virus NS1 protein prevents activation of NF-kB and induction of alpha/beta interferon. J Virol 74, 11566-11573.
46. Zielecki, F., Semmler, I., Kalthoff, D., Voss, D., Mauel, S., Gruber, A. D., Beer, M. & Wolff, T. (2010). Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. J Virol 84, 10708-10718.